Sotagliflozin
Chemical Structure Depiction of
Sotagliflozin
Sotagliflozin
Compound characteristics
| Compound ID: | CE03-9847 |
| Compound Name: | Sotagliflozin |
| Molecular Weight: | 424.94 |
| Molecular Formula: | C21 H25 Cl O5 S |
| CAS Number: | 1018899-04-1 |
| Smiles: | CCOc1ccc(Cc2cc(ccc2[Cl])[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)SC)O)O)O)cc1 |
| InChI Key: | QKDRXGFQVGOQKS-XIYVOTBMSA-N |
| Short Description: | Sotagliflozin (LP-802034) is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and 2 (SGLT2), with potential antihyperglycemic activity. |
| Pathway: | GPCR/G Protein |
| Target: | SGLT |
| Type of molecule: | FDA Approved/Clinical |
| Alias: | LX-4211 , LP-802034 |
| Stock amount: | 3581 |